Lakefront Biotherapeutics (LKFT) Change in Taxes (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported Change in Taxes of -$81952.2 for Q1 2026, up 65.22% year-over-year from -$49602.2 in Q1 2025, and up 99.81% quarter-over-quarter from -$43.6 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Change in Taxes (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 11 years of Change in Taxes data on file, last reported at -$81952.2 in Q1 2026.
- Change in Taxes for Q1 2026 came in at -$81952.2, up 65.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.8 million (down 987.58% YoY), and the FY2025 annual result was -$21.1 million, down 1058.83% from the prior year.
- Change in Taxes improved to -$81952.2 in Q1 2026 per LKFT's latest filing, from -$43.6 million in the prior quarter.
- Over five years, Change in Taxes peaked at $23.2 million in Q3 2025 and troughed at -$43.6 million in Q4 2025.
- A 5-year average of -$2.0 million and a median of -$292132.8 in 2025 frame the typical range for Change in Taxes.
- On a YoY basis, Change in Taxes climbed as much as 1066.89% in 2025 and fell as far as 40667.84% in 2025.
- A 5-year view of Change in Taxes shows it stood at $6.2 million in 2022, then slumped by 136.47% to -$2.3 million in 2023, then jumped by 95.27% to -$106859.5 in 2024, then sank by 40667.84% to -$43.6 million in 2025, then soared by 99.81% to -$81952.2 in 2026.
- Business Quant data shows LKFT's Change in Taxes at -$81952.2 in Q1 2026, -$43.6 million in Q4 2025, and $23.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | -81,952.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81,952.20 |
| Mar 31, 2026 | -81,952.20 |
| Dec 31, 2025 | -43.56 Mn |
| Dec 31, 2025 | -43.56 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | -348,643.58 |
| Jun 30, 2025 | -348,643.58 |
| Mar 31, 2025 | -235,622.11 |
| Mar 31, 2025 | -235,622.11 |
| Dec 31, 2024 | -106,859.54 |
| Dec 31, 2024 | -106,859.54 |
| Sep 30, 2024 | 1.99 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 703,207.59 |
| Jun 30, 2024 | 703,207.59 |
| Mar 31, 2024 | -815,857.69 |
| Mar 31, 2024 | -815,857.69 |
| Dec 31, 2023 | -2.26 Mn |
| Dec 31, 2023 | -2.26 Mn |